Treatment of neocoronitis includes antiviral therapy, immunotherapy and glucocorticoid therapy. 1. Antiviral treatment. There is no effective antiviral drug, the drug can be tried and the efficacy can be further evaluated in clinical application. However, attention should be paid to the adverse reactions, contraindications and interactions with other drugs. (1) Alpha-interferon nebulized inhalation. (2) Ribavirin is recommended to be applied in combination with interferon, lopinavir and ritonavir. (3) Application of chloroquine phosphate, abidol, etc. 2. Immunotherapy (1) Recovering plasma for recovered patients: suitable for patients with rapid disease progression, heavy and critical types. (2) Hydrostatic injection of COVID-19 human immunoglobulin: it can be used urgently for patients with faster progression of disease, general type and heavy type. (3) Tolizumab: It can be tried in patients with extensive lesions in both lungs and in heavy patients with elevated IL-6 levels in laboratory tests. Allergic reactions should be noted, and it is contraindicated in patients with active infections such as tuberculosis. 3. Glucocorticoid therapy For patients with progressive deterioration of oxygenation indexes, rapid progression of imaging, and over-activation of the body’s inflammatory response, glucocorticoids, such as intravenous methylprednisolone, should be used for a short period of time as appropriate. There is no definitive drug for new coronavirus pneumonia. It is necessary to actively prevent new coronavirus infection, minimize outdoor activities, pay attention to personal protection, and do health monitoring. Tips] In this article, “new coronary pneumonia, new coronary virus pneumonia” has been renamed to “new coronary virus infection” on December 26, 2022, as announced by the National Health Commission.